63 results
S-3ASR
EX-5.1
CRNX
Crinetics Pharmaceuticals Inc
19 Mar 24
Automatic shelf registration
4:05pm
Statement.
As counsel for the Company, we have examined originals or copies, certified or otherwise identified to our satisfaction, of the Registration
8-K
EX-10.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
and sale of the Shares to the Purchasers by the Company (the “Closing”) will occur, subject to the satisfaction or waiver of the conditions set forth … to the satisfaction of certain conditions (if applicable), including, among other things, the existence of a public market for the securities
8-K
EX-99.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
, before deducting any offering-related expenses. The private placement is expected to close on or about March 1, 2024, subject to the satisfaction … , including statements regarding Crinetics’ expectations of market conditions and the satisfaction of customary closing conditions related to the private
S-8
EX-5.1
CRNX
Crinetics Pharmaceuticals Inc
28 Feb 24
Registration of securities for employees
6:04pm
for the Company, we have examined originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records
8-K
EX-1.1
slg4nh
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
8-K
EX-99.1
hibva
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
8-K
EX-99.2
lyorf9h0v1tr
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
8-K
vahi q4fbzwas2m
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
424B5
bnnbz7p0fb 9m8zodb
13 Sep 23
Prospectus supplement for primary offering
5:19pm
424B5
dad34d tto
11 Sep 23
Prospectus supplement for primary offering
4:09pm
8-K
ft4231657h1rv3eka9i
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
8-K
EX-1.1
xtz2fzwzt6jtalb5p
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
8-K
EX-99.1
lj8e9j4a
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
8-K
EX-10.1
7qlxrbp7lj udk
23 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
v1orczx56cl6t7i
8 Nov 21
Other Events
8:53am